Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis
Adèle Coriati, S. Ziai, Annick Lavoie, et al.
Acta Diabetologica (2015) Vol. 53, Iss. 3, pp. 359-366
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis
Andrea Granados, Christine L. Chan, Katie Larson Ode, et al.
Journal of Cystic Fibrosis (2019) Vol. 18, pp. S3-S9
Open Access | Times Cited: 125
ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis
Michael Wilschanski, À. Munck, Estefania Carrion, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 2, pp. 413-445
Closed Access | Times Cited: 27
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
Saba Sheikh, Lalitha Gudipaty, Diva D. De León, et al.
Diabetes (2016) Vol. 66, Iss. 1, pp. 134-144
Open Access | Times Cited: 73
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents
Katie Larson Ode, Manfred Ballman, Alberto Battezzati, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1212-1228
Open Access | Times Cited: 33
Combined Exercise Training Improves Glycemic Control in Adult with Cystic Fibrosis
Nadia Beaudoin, Guillaume F. Bouvet, Adèle Coriati, et al.
Medicine & Science in Sports & Exercise (2016) Vol. 49, Iss. 2, pp. 231-237
Closed Access | Times Cited: 49
Islet-intrinsic effects of CFTR mutation
Fiona N. Manderson Koivula, Neville H. McClenaghan, Alan G.S. Harper, et al.
Diabetologia (2016) Vol. 59, Iss. 7, pp. 1350-1355
Open Access | Times Cited: 47
Cystic Fibrosis: Emerging Understanding and Therapies
Michael M. Rey, Michael Bonk, Denis Hadjiliadis
Annual Review of Medicine (2018) Vol. 70, Iss. 1, pp. 197-210
Open Access | Times Cited: 45
Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes
Valérie Boudreau, Adèle Coriati, Katherine Desjardins, et al.
Journal of Cystic Fibrosis (2016) Vol. 15, Iss. 2, pp. 258-260
Open Access | Times Cited: 42
Cystic fibrosis related diabetes: Medical management
Katie Larson Ode, Christine L. Chan, Andrea Granados, et al.
Journal of Cystic Fibrosis (2019) Vol. 18, pp. S10-S18
Open Access | Times Cited: 38
Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges
Valérie Boudreau, Quitterie Reynaud, Catherine Lehoux Dubois, et al.
Canadian Journal of Diabetes (2016) Vol. 40, Iss. 5, pp. 466-470
Closed Access | Times Cited: 38
Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Catherine Mainguy, G. Bellon, V. Delaup, et al.
Journal of Pediatric Endocrinology and Metabolism (2016) Vol. 30, Iss. 1
Closed Access | Times Cited: 33
20 years of the Montreal Cystic Fibrosis Related Diabetes Screening Cohort: key insights
Laure Alexandre‐Heymann, Valérie Boudreau, Dean Lim, et al.
European Respiratory Review (2025) Vol. 34, Iss. 176, pp. 240220-240220
Open Access
Unique challenges of cystic fibrosis‐related diabetes
Nicola Bridges, Rachel Rowe, R. I. G. Holt
Diabetic Medicine (2018) Vol. 35, Iss. 9, pp. 1181-1188
Open Access | Times Cited: 32
Advances in cystic fibrosis-related diabetes: Current status and future directions
F. Lurquin, Martin Buysschaert, Vanessa Preumont
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 11, pp. 102899-102899
Open Access | Times Cited: 8
Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study
Florence Racine, Azadeh Shohoudi, Valérie Boudreau, et al.
Canadian Journal of Diabetes (2021) Vol. 45, Iss. 8, pp. 768-774
Closed Access | Times Cited: 13
Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia
Catherine Lehoux Dubois, Valérie Boudreau, François Tremblay, et al.
Journal of Cystic Fibrosis (2017) Vol. 16, Iss. 3, pp. 418-424
Open Access | Times Cited: 13
Glucose trajectories in cystic fibrosis and their association with pulmonary function
Quitterie Reynaud, Muriel Rabilloud, Sylvain Roche, et al.
Journal of Cystic Fibrosis (2017) Vol. 17, Iss. 3, pp. 400-406
Open Access | Times Cited: 13
Cystic fibrosis year in review 2016
Adrienne P. Savant, Susanna A. McColley
Pediatric Pulmonology (2017) Vol. 52, Iss. 8, pp. 1092-1102
Open Access | Times Cited: 12
The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening
Grace Y. Lam, Michelle Doll-Shankaruk, Jan Dayton, et al.
Journal of Cystic Fibrosis (2017) Vol. 17, Iss. 1, pp. 121-124
Open Access | Times Cited: 12
Ventilation inhomogeneity is associated with OGTT‐derived insulin secretory defects in cystic fibrosis
Carla Colombo, Gianfranco Alicandro, Simone Gambazza, et al.
Pediatric Pulmonology (2018) Vol. 54, Iss. 2, pp. 141-149
Closed Access | Times Cited: 11
Glucose tolerance in Canadian and French cystic fibrosis adult patients
Quitterie Reynaud, Valérie Boudreau, Sandrine Touzet, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period
Valérie Boudreau, Quitterie Reynaud, Angélique Denis, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0246897-e0246897
Open Access | Times Cited: 9
Combined Indeterminate and Impaired Glucose Tolerance Is a Novel Group at High Risk of Cystic Fibrosis-Related Diabetes
Kathryn J. Potter, Quitterie Reynaud, Valérie Boudreau, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 10, pp. e3901-e3910
Open Access | Times Cited: 9
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
Johann Colomba, Silvia R. Netedu, C. Lehoux-Dubois, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0219855-e0219855
Open Access | Times Cited: 9
Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review
S. Kumar, Michael Pallin, Georgia Soldatos, et al.
Journal of Clinical & Translational Endocrinology (2022) Vol. 30, pp. 100305-100305
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top